Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

Fornage M, Lee CR, Doris PA, Bray MS, Heiss G, Zeldin DC, Boerwinkle E.

Hum Mol Genet. 2005 Oct 1;14(19):2829-37. Epub 2005 Aug 22.

2.

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

Lee CR, North KE, Bray MS, Fornage M, Seubert JM, Newman JW, Hammock BD, Couper DJ, Heiss G, Zeldin DC.

Hum Mol Genet. 2006 May 15;15(10):1640-9. Epub 2006 Apr 4.

3.

Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans.

Gschwendtner A, Ripke S, Freilinger T, Lichtner P, Müller-Myhsok B, Wichmann HE, Meitinger T, Dichgans M.

Stroke. 2008 May;39(5):1593-6. doi: 10.1161/STROKEAHA.107.502179. Epub 2008 Mar 6.

4.

Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.

Fava C, Montagnana M, Danese E, Almgren P, Hedblad B, Engström G, Berglund G, Minuz P, Melander O.

Pharmacogenet Genomics. 2010 Feb;20(2):94-103. doi: 10.1097/FPC.0b013e3283349ec9.

PMID:
20065888
5.
6.

Single nucleotide polymorphisms associated with coronary heart disease predict incident ischemic stroke in the atherosclerosis risk in communities study.

Morrison AC, Bare LA, Luke MM, Pankow JS, Mosley TH, Devlin JJ, Willerson JT, Boerwinkle E.

Cerebrovasc Dis. 2008;26(4):420-4. doi: 10.1159/000155637. Epub 2008 Sep 18.

7.

Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease.

Lee J, Dahl M, Grande P, Tybjaerg-Hansen A, Nordestgaard BG.

Stroke. 2010 Jan;41(1):27-33. doi: 10.1161/STROKEAHA.109.567768. Epub 2009 Nov 25.

8.

Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study.

Volcik KA, Ballantyne CM, Braun MC, Coresh J, Mosley TH, Boerwinkle E.

Am J Hypertens. 2008 May;21(5):533-8. doi: 10.1038/ajh.2007.81. Epub 2008 Feb 21.

9.

Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking.

Wei Q, Doris PA, Pollizotto MV, Boerwinkle E, Jacobs DR Jr, Siscovick DS, Fornage M.

Atherosclerosis. 2007 Jan;190(1):26-34. Epub 2006 Mar 20.

PMID:
16545818
10.

Sequence variation in telomerase reverse transcriptase (TERT) as a determinant of risk of cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) study.

Bressler J, Franceschini N, Demerath EW, Mosley TH, Folsom AR, Boerwinkle E.

BMC Med Genet. 2015 Jul 23;16:52. doi: 10.1186/s12881-015-0194-x.

11.

Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women.

Howard TD, Giles WH, Xu J, Wozniak MA, Malarcher AM, Lange LA, Macko RF, Basehore MJ, Meyers DA, Cole JW, Kittner SJ.

Stroke. 2005 Sep;36(9):1848-51. Epub 2005 Aug 11.

12.

Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study.

Olson NC, Butenas S, Lange LA, Lange EM, Cushman M, Jenny NS, Walston J, Souto JC, Soria JM, Chauhan G, Debette S, Longstreth WT, Seshadri S, Reiner AP, Tracy RP.

J Thromb Haemost. 2015 Oct;13(10):1867-77. doi: 10.1111/jth.13111. Epub 2015 Sep 14.

13.

Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.

Koerner IP, Jacks R, DeBarber AE, Koop D, Mao P, Grant DF, Alkayed NJ.

J Neurosci. 2007 Apr 25;27(17):4642-9.

14.

Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population.

Zhang L, Ding H, Yan J, Hui R, Wang W, Kissling GE, Zeldin DC, Wang DW.

Pharmacogenet Genomics. 2008 Jan;18(1):45-51. doi: 10.1097/FPC.0b013e3282f313e8.

15.

CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke.

Yi X, Zhang B, Wang C, Liao D, Lin J, Chi L.

Gene. 2015 Jul 1;565(1):85-9. doi: 10.1016/j.gene.2015.03.068. Epub 2015 Mar 31.

PMID:
25839935
16.

Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.

Corenblum MJ, Wise VE, Georgi K, Hammock BD, Doris PA, Fornage M.

Hypertension. 2008 Feb;51(2):567-73. Epub 2007 Dec 17.

17.

Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study.

Carty CL, Cushman M, Jones D, Lange LA, Hindorff LA, Rice K, Jenny NS, Durda JP, Walston J, Carlson CS, Nickerson D, Tracy RP, Reiner AP.

Thromb Haemost. 2008 Feb;99(2):388-95. doi: 10.1160/TH07-08-0523.

PMID:
18278190
18.

Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study.

Kohsaka S, Volcik KA, Folsom AR, Wu KK, Ballantyne CM, Willerson JT, Boerwinkle E.

Atherosclerosis. 2008 Feb;196(2):926-30. Epub 2007 Mar 9.

PMID:
17350020
19.

Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study.

Burdon KP, Lehtinen AB, Langefeld CD, Carr JJ, Rich SS, Freedman BI, Herrington D, Bowden DW.

Diab Vasc Dis Res. 2008 Jun;5(2):128-34. doi: 10.3132/dvdr.2008.021.

20.

Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury.

Fornage M, Mosley TH, Jack CR, de Andrade M, Kardia SL, Boerwinkle E, Turner ST.

Hum Genet. 2007 Jan;120(5):671-80. Epub 2006 Sep 22.

PMID:
17024375

Supplemental Content

Support Center